Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Intermediate Cervical Plexus Block

ConditionAnalgesia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21-60
SponsorDamanhour Teaching Hospital

About this trial

Background: Many thyroidectomy patients suffer from postoperative pain that could delay early hospital discharge and place a significant burden on both the patient and the healthcare team. Bilateral intermediate cervical plexus block (ICPB) provides good analgesia for neck surgery, including thyroidectomy. However, the duration of a single-shot nerve block is usually short. Therefore, adjuvants are used in peripheral nerve blocks.

Objectives: To compare the safety and efficacy of dexmedetomidine versus dexamethasone as adjuvants to bupivacaine in ultrasound-guided intermediate cervical plexus block in patients undergoing total thyroidectomy under general anesthesia.

Patients and Methods: This is a randomized, double-blind, phase four, prospective clinical trial; carried out on 60 patients, who were candidates for total thyroidectomy under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group A, received bilateral ICPB with isobaric bupivacaine plus dexmedetomidine, and group B, received bilateral ICPB with isobaric bupivacaine plus dexamethasone.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) physical status ≤ II

Age from 21 to 60 years

Body Mass Index (BMI) ≤ 35 kg/m2

Disqualifiers

ASA physical status > II

Age < 21 years or > 50 years

BMI > 35 kg/m2

Bronchial asthma

Trial design

Treatments tested in this trial

  • Dexmedetomidine Hydrochloride
  • Dexamethasone Phosphate

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators